Melanoma
Showing NaN - NaN of 85
Urothelial Carcinoma, Head Neck Cancer, Melanoma Trial in Canada, Spain, United States (Autologous genetically modified MAGE
Completed
- Urothelial Carcinoma
- +3 more
- Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells
-
Boston, Massachusetts
- +10 more
Dec 17, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Melanoma Trial in Worldwide (pembrolizumab + epacadostat, pembrolizumab + )
Completed
- Melanoma
- pembrolizumab + epacadostat
- pembrolizumab + placebo
-
Birmingham, Alabama
- +128 more
Aug 14, 2020
Breast Cancer, Lung Cancer, Melanoma Trial in Nashville (1-methyl-D-tryptophan)
Terminated
- Breast Cancer
- +4 more
-
Nashville, TennesseeVanderbilt University
May 26, 2020
Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)
Melanoma Trial in United States (glembatumumab vedotin, glembatumumab vedotin and varlilumab, glembatumumab vedotin and PD-1
Terminated
- Melanoma
- glembatumumab vedotin
- +3 more
-
Los Angeles, California
- +13 more
Sep 5, 2019
Melanoma Trial in Worldwide (Tasisulam-sodium, Paclitaxel)
Terminated
- Melanoma
-
Birmingham, Alabama
- +121 more
Jun 18, 2018
Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)
Terminated
- Melanoma
- Metastatic Melanoma
- Vemurafenib
- +2 more
-
Los Angeles, California
- +13 more
Sep 22, 2017
Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer Trial in Italy, Spain, United States (MSC1936369B
Completed
- Locally Advanced Solid Tumor
- +5 more
- MSC1936369B (pimasertib)
- SAR245409 (PI3K and mTOR inhibitor)
-
Scottsdale, Arizona
- +7 more
Jan 17, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Melanoma Trial in Worldwide (Talimogene laherparepvec, GM-CSF)
Completed
- Melanoma
- Talimogene laherparepvec
- GM-CSF
-
Tucson, Arizona
- +82 more
Jun 14, 2016
Cancer, Melanoma Trial in United States (Sorafenib (Nexavar, BAY43-9006), Placebo, Dacarbazine)
Completed
- Cancer
- Melanoma
- Sorafenib (Nexavar, BAY43-9006)
- +2 more
-
Tucson, Arizona
- +13 more
May 13, 2015
Melanoma Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Carboplatin/Paclitaxel, Placebo)
Completed
- Melanoma
- Sorafenib (Nexavar, BAY43-9006)
- +2 more
-
Birmingham, Alabama
- +65 more
Oct 23, 2014